Page last updated: 2024-10-24

negative regulation of receptor binding

Definition

Target type: biologicalprocess

Any process that stops, prevents or reduces the frequency, rate or extent of a protein or other molecule binding to a receptor. [GOC:signaling, GOC:TermGenie]

Negative regulation of receptor binding is a complex biological process that involves a variety of mechanisms to modulate the interaction between signaling molecules, such as hormones, neurotransmitters, and growth factors, and their corresponding receptors on the cell surface. This process is essential for maintaining cellular homeostasis and ensuring appropriate responses to external stimuli. Here's a detailed breakdown of the mechanisms involved:

1. **Ligand Binding Inhibition:** This involves preventing the ligand from binding to the receptor by:
* **Competing Ligands:** Substances that resemble the natural ligand can bind to the receptor site, preventing the actual ligand from binding.
* **Receptor Antagonists:** These molecules bind to the receptor but do not activate it, essentially blocking the receptor from being activated by the ligand.
* **Ligand Sequestration:** Molecules can bind to and sequester the ligand, preventing it from reaching the receptor.

2. **Receptor Modulation:** This involves altering the receptor itself to reduce its ability to bind the ligand or to signal downstream:
* **Receptor Desensitization:** Repeated stimulation of the receptor can lead to a decrease in its responsiveness. This often involves phosphorylation of the receptor, which can cause it to be internalized or to bind to other proteins that inhibit its signaling activity.
* **Receptor Downregulation:** This involves a decrease in the total number of receptors on the cell surface. This can occur through receptor endocytosis and degradation.
* **Receptor Masking:** Other proteins can bind to the receptor and physically block the ligand binding site.

3. **Signaling Pathway Inhibition:** This involves interfering with the downstream signaling pathways activated by the receptor:
* **Inhibitory Proteins:** These proteins can bind to and inactivate signaling molecules downstream of the receptor, such as protein kinases or phosphatases.
* **Protein Degradation:** Signaling molecules can be degraded, preventing them from continuing the signal.
* **Feedback Inhibition:** Downstream signaling components can feedback to inhibit the receptor itself or earlier components in the pathway.

4. **Cellular Context and Regulation:** The regulation of receptor binding is influenced by the cellular context, such as the presence of other signaling molecules, the cell's differentiation state, and its overall metabolic status. This means that negative regulation can be highly specific and tailored to the needs of the cell.

In summary, negative regulation of receptor binding is a multifaceted process involving a variety of mechanisms that can act at different levels to dampen or fine-tune the cellular response to signaling molecules. This intricate regulation ensures that cells respond appropriately to their environment and maintain homeostasis.'
"

Proteins (3)

ProteinDefinitionTaxonomy
Sarcoplasmic/endoplasmic reticulum calcium ATPase 3A sarcoplasmic/endoplasmic reticulum calcium ATPase 3 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q93084]Homo sapiens (human)
Sarcoplasmic/endoplasmic reticulum calcium ATPase 2A sarcoplasmic/endoplasmic reticulum calcium ATPase 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P16615]Homo sapiens (human)
Receptor-type tyrosine-protein phosphatase FA receptor-type tyrosine-protein phosphatase F that is encoded in the genome of human. [PRO:DNx, UniProtKB:P10586]Homo sapiens (human)

Compounds (20)

CompoundDefinitionClassesRoles
4-hydroxyphenylglyoxylic acid4-hydroxyphenylglyoxylate : Conjugate base of 4-hydroxyphenylglyoxylic acid.

4-hydroxyphenylglyoxylic acid: RN given refers to parent cpd
phenols
5-iodo-2-(oxaloamino)benzoic acidorganoiodine compound
2,5-di-tert-butylhydroquinone2,5-di-tert-butylbenzene-1,4-diol : A member of the class of hydroquinones that is benzene-1,4-diol substituted by tert-butyl groups at position 2 and 5.hydroquinones
oleanolic acidhydroxy monocarboxylic acid;
pentacyclic triterpenoid
plant metabolite
vanadatesvanadate(3-) : A vanadium oxoanion that is a trianion with formula VO4 in which the vanadium is in the +5 oxidation state and is attached to four oxygen atoms.

Vanadates: Oxyvanadium ions in various states of oxidation. They act primarily as ion transport inhibitors due to their inhibition of Na(+)-, K(+)-, and Ca(+)-ATPase transport systems. They also have insulin-like action, positive inotropic action on cardiac ventricular muscle, and other metabolic effects.
trivalent inorganic anion;
vanadium oxoanion
EC 3.1.3.1 (alkaline phosphatase) inhibitor;
EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor;
EC 3.1.3.41 (4-nitrophenylphosphatase) inhibitor;
EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor
ursolic acidhydroxy monocarboxylic acid;
pentacyclic triterpenoid
geroprotector;
plant metabolite
maslinic acid(2Alpha,3beta)-2,3-dihydroxyolean-12-en-28-oic acid: from Luehea divaricata and Agrimonia eupatoriadihydroxy monocarboxylic acid;
pentacyclic triterpenoid
anti-inflammatory agent;
antineoplastic agent;
antioxidant;
plant metabolite
paxillinepaxilline : An indole diterpene alkaloid with formula C27H33NO4 isolated from Penicillium paxilli. It is a potent inhibitor of large conductance Ca2(+)- and voltage-activated K(+) (BK)-type channels.

paxilline: structure given in first source; RN given refers to (2R-(2alpha,4bbeta,6aalpha,12bbeta,12calpha,14abeta))-isomer
diterpene alkaloid;
enone;
organic heterohexacyclic compound;
terpenoid indole alkaloid;
tertiary alcohol
anticonvulsant;
Aspergillus metabolite;
EC 3.6.3.8 (Ca(2+)-transporting ATPase) inhibitor;
genotoxin;
geroprotector;
mycotoxin;
Penicillium metabolite;
potassium channel blocker
cryptotanshinonecryptotanshinone: from Salvia miltiorrhizaabietane diterpenoidanticoronaviral agent
2-(oxaloamino)benzoic acid(oxaloamino)benzoic acid
moronic acidmoronic acid : A pentacyclic triterpenoid that is olean-18-ene substituted at position 3 by an oxo group and position 28 by a carboxy group.

moronic acid: from root bark extract of Ozoroa mucronata; RN & N1 from 9th CI
pentacyclic triterpenoidanti-HIV agent;
anti-HSV-1 agent;
metabolite
morolic acidmorolic acid: from Pistacia terebinthus galls; structure in first source
cefsulodincefsulodin : A pyridinium-substituted semi-synthetic, broad-spectrum, cephalosporin antibiotic.

Cefsulodin: A pyridinium-substituted semisynthetic, broad-spectrum antibacterial used especially for Pseudomonas infections in debilitated patients.
cephalosporin;
organosulfonic acid;
primary carboxamide
antibacterial drug
curcumincurcumin : A beta-diketone that is methane in which two of the hydrogens are substituted by feruloyl groups. A natural dyestuff found in the root of Curcuma longa.

Curcumin: A yellow-orange dye obtained from tumeric, the powdered root of CURCUMA longa. It is used in the preparation of curcuma paper and the detection of boron. Curcumin appears to possess a spectrum of pharmacological properties, due primarily to its inhibitory effects on metabolic enzymes.
aromatic ether;
beta-diketone;
diarylheptanoid;
enone;
polyphenol
anti-inflammatory agent;
antifungal agent;
antineoplastic agent;
biological pigment;
contraceptive drug;
dye;
EC 1.1.1.205 (IMP dehydrogenase) inhibitor;
EC 1.1.1.21 (aldehyde reductase) inhibitor;
EC 1.1.1.25 (shikimate dehydrogenase) inhibitor;
EC 1.6.5.2 [NAD(P)H dehydrogenase (quinone)] inhibitor;
EC 1.8.1.9 (thioredoxin reductase) inhibitor;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor;
EC 3.5.1.98 (histone deacetylase) inhibitor;
flavouring agent;
food colouring;
geroprotector;
hepatoprotective agent;
immunomodulator;
iron chelator;
ligand;
lipoxygenase inhibitor;
metabolite;
neuroprotective agent;
nutraceutical;
radical scavenger
illudalic acidilludalic acid: isolated from Clitocybe illudens; structure in first source
2-amino-6-chloropurine6-chloroguanine : An organochlorine compound that is 7H-purin-2-amine substituted by a chloro group at position 6.

6-chloroguanine: an antimalarial that inhibits hypoxanthine-guanine-xanthine phosphoribosyltransferase; structure in first source
2-aminopurines;
organochlorine compound
corosolic acidtriterpenoidmetabolite
3-(1-(3-(biphenyl-4-ylamino)-3-oxopropyl)-1h-1,2,3-triazol-4-yl)-6-hydroxy-1-methyl-2-phenyl-1h-indole-5-carboxylic acid3-(1-(3-(biphenyl-4-ylamino)-3-oxopropyl)-1H-1,2,3-triazol-4-yl)-6-hydroxy-1-methyl-2-phenyl-1H-indole-5-carboxylic acid: an SHP2 inhibitor; structure in first source
biselyngbyasidebiselyngbyaside: antineoplastic from the marine cyanobacterium Lyngbya sp.; structure in first source
alpha-cyclopiazonic acidalpha-cyclopiazonic acids